RG-12525 是一種特異性的,競爭性的,可口服的 LTC4,LTD4 和 LTE4 拮抗劑,也是 <b>PPAR-γ</b> 的激動劑,<b>IC<sub>50</sub></b> 值約為 60 nM,<b>CYP3A4</b> 的抑制劑, K<sub>i</sub> 值為 0.5 µM。<BR><a href="https://www.medchemexpress.cn/9-Aminocamptothecin.html">9-Aminocamptothecin</a>產(chǎn)品描述:9-Aminocamptothecin is a <b>topoisomerase I</b> inhibitor with potent anticancer activity.IC50 & Target: Topoisomerase<sup>[1]</sup><i><b>In Vitro:</b></i> In human breast (MCF-7), bladder (MGH-U1), and colon (HT-29) cancer cell lines, 9-Aminocamptothecin cytotoxicity increases with both higher drug concentrations and longer exposure times. Minimal cell killing is also observed unless 9-Aminocamptothecin concentrations exceeds a threshold of 2.7 nm<sup>[1]</sup>. 9-Aminocamptothecin inhibits PC-3, PC-3M, DU145, and LNCaP cells with IC<sub>50</sub> values of 34.1, 10, 6.5, and 8.9 nM, respectively after 96 h of drug exposure<sup>[2]</sup>.<i><b>In Vivo:</b></i> 9-Aminocamptothecin inhibits tumor growth at the lowest oral dose (0.35 mg/kg/day), wheras higher oral doses (0.75 and 1 mg/kg/day) and s.c. administration (4 mg/kg/week) causes tumor regression. 9-Aminocamptothecin is well tolerated at all doses, with no toxic death or weight loss of more than 10% observed in any group<s<br><br><br><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">公司介紹:MedChemExpress(MCE)專注于各種抑制劑、激動劑、API及化合物庫,總部位于美國新澤西,分別在瑞典和上海設(shè)有歐洲區(qū)子公司和亞洲區(qū)總代理,營銷網(wǎng)點遍及全球20多個國家地區(qū)。MCE經(jīng)過多年努力已成為全球生物活性小分子領(lǐng)域的一流供應商, 產(chǎn)品涵蓋癌癥、神經(jīng)科學、抗感染、表觀遺傳學等20個熱門研究領(lǐng)域,PI3K、MAPK等近千個細分靶點,超過4000個活性小分子化合物現(xiàn)貨,以及GPCR、API、離子通道等超過20種不同類型的化合物庫,同時提供從毫克到千克的專業(yè)定制合成服務。</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">MCE 對每批產(chǎn)品都進行嚴格的LCMS和NMR檢驗,其產(chǎn)品已被全球近萬名客戶廣泛使用并發(fā)表大量文章、專利;</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">MCE 定期增加各領(lǐng)域熱門抑制劑、激動劑,不斷擴增已有化合物庫,以滿足最新的科研需求;</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">數(shù)千種產(chǎn)品在上海有充足備貨,24-48小時內(nèi)送達客戶;</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">大量產(chǎn)品提供免費試用裝;</span><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">已為全球多個知名企業(yè)、院校構(gòu)建各種定制型化合物庫。</span><br><br>產(chǎn)品鏈接:<a href="http://www.medchemexpress.cn/9-Aminocamptothecin.html">www.medchemexpress.cn/9-Aminocamptothecin.html</a><br><br></span><img style="width: 600.0px;height: 310.0px;" src="http://img.dxycdn.com/trademd/upload/userfiles/image/2014/08/A1408605159png_small.jpg" alt="">Purity:98%<BR>MWt:423.4665<BR>Formula:C25H21N5O2<BR>SMILES:C1(COC2=CC=C(OCC3=CC=CC=C3CC4=NN=NN4)C=C2)=NC5=CC=CC=C5C=C1<BR>Pathway:Cell Cycle/DNA Damage; GPCR/G Protein; metabolic Enzyme/Protease; NF-κB; <BR>Mechanisms:Cytochrome P450; Leukotriene Receptor; PPAR; <BR>Research Area:metabolic Disease<BR>電話: 021-58955995<BR>網(wǎng)址: www.MedChemExpress.cn <BR>地址: 上海市浦東新區(qū)蔡倫路720號2號樓3層 |
RG-12525前沿研究進展
發(fā)布日期:2017-11-13 瀏覽次數(shù):0
核心提示:RG-12525 是一種特異性的,競爭性的,可口服的 LTC4,LTD4 和 LTE4 拮抗劑,也是 bPPAR-/b 的激動劑,bICsub50/sub/b 值約為 60
- 下一篇:暫無
- 上一篇:Setipafant前沿研究進展
行業(yè)動態(tài)
更多...
- RG-12525前沿研究進展 11-13
- Setipafant前沿研究進展 11-13
- Tiapamil (hydrochloride) 11-13
- MTPPA前沿研究進展 11-13
- TDN345前沿研究進展 11-13
- Sulamserod前沿研究進展 11-13
- Win 58237前沿研究進展 11-13
- Nifursemizone前沿研究進 11-13
- Pargolol (hydrochloride) 11-13
- COX2-IN-1前沿研究進展 11-13